REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanghai Henlius Biotech, Inc. (Shanghai) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Henlius Biotech, Inc. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Henlius Biotech, Inc. is a company located in Shanghai. The company's incorporation date and history are not mentioned in the source. The main products and services offered by the company are not mentioned in the source. The customers and main markets of the company are also not mentioned in the source.

Headquarters
9Th Floor, Block A, Innov Tower, 1801 Hongmei Road, Xuhui District
Shanghai; Shanghai;

Contact Details: Purchase the Shanghai Henlius Biotech, Inc. (Shanghai) report to view the information.

Website: http://www.henlius.com

Basic Information
Total Employees:
Purchase the Shanghai Henlius Biotech, Inc. (Shanghai) report to view the information.
Outstanding Shares:
Purchase the Shanghai Henlius Biotech, Inc. (Shanghai) report to view the information.
Registered Capital:
Purchase the Shanghai Henlius Biotech, Inc. (Shanghai) report to view the information.
Financial Auditors:
Purchase the Shanghai Henlius Biotech, Inc. (Shanghai) report to view the information.
Incorporation Date:
February 24, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
48.94%
Purchase this report to view the information.
9.55%
Purchase this report to view the information.
4.39%
Purchase this report to view the information.
2.09%
Purchase this report to view the information.
1.68%
Subsidiaries
Aton (Guangzhou) Biotech Co., Ltd
100%
Hengenix Biotech, Inc. (United States)
100%
Henlius Europe Gmbh (Germany)
100%
Company Performance
Financial values in the chart are available after Shanghai Henlius Biotech, Inc. (Shanghai) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
67.82%
Total operating revenue
69.74%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
10.97%
Total equity
33.98%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-38.02%
Quick Ratio
0.09%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?